Vitalhub Corp.

TSX:VHI.TO

Medical - Healthcare Information Services

Healthcare
$6.66 +0.56%

+$0.04 today

Market cap
$421.84M
Beta
0.77
P/E (TTM)
62.1
EPS (TTM)
$0.12
52W Low $6.67High $14.64

Volume 0.23M

Average 0.41M

VHI.TO EBITDA Margin

EBITDA as a percentage of revenue.

Vitalhub Corp.TSX: VHI.TO

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to 24.3%

EBITDA Margin was 24.3% in Q1 FY2026, up 7.3 pp from a year earlier. On a trailing-twelve-month basis it was 20.3%, up 3.9 pp year over year. Over 3 fiscal years it widened by 8.2 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 7 analysts of 16.1% for the fiscal year ending Dec 2026, down from 21.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
24.3%+1.2 pp QoQ
Last fiscal yearDec 2025
21.3%+4.0 pp YoY
LTMMar 2026
20.3%+3.9 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+7.3 pp+10.6 pp+3.3 pp
1 year+4.0 pp-5.2 pp-9.2 pp
3 years+8.2 pp-1.3 pp-9.5 pp
5 years-4.6 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
21.3%
Year-over-year change
+4.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How VHI.TO compares with its peers on the latest reported figures

  • VHI.TO's LTM Mar 2026 EBITDA Margin of 20.3% is the 3rd highest of the 7 companies compared; the peer median is 15.9%.
  • Its year-over-year change of +3.9 pp is the 3rd highest of 7, against a peer median of -5.5 pp.
  • Over three fiscal years its change of +8.2 pp compares with a peer median of +12.9 pp.
VHI.TO Competitors Peer median
EBITDA Margin for VHI.TO and competitors
Company Period LTM level YoY 3-year change
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202649.3% +16.9 pp-11.3 pp
TSND.TOTerrAscend Corp.LTM Mar 202623.1% +19.6 pp+126.3 pp
VHI.TOVitalhub Corp.LTM Mar 202620.3% +3.9 pp+8.2 pp
KSI.TOKneat.com, Inc.LTM Mar 202619.0% -5.2 pp+22.3 pp
GUD.TOKnight Therapeutics Inc.LTM Mar 202612.8% -5.8 pp+3.5 pp
ACB.TOAurora Cannabis Inc.LTM Mar 20263.1% -11.9 pp+39.6 pp
EDT.TOSpectral Medical Inc.LTM Mar 2026-1275.3% -390.0 pp-37.5 pp
Peer median (excluding VHI.TO) 15.9%-5.5 pp+12.9 pp

Competitors are the stored peer set for VHI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue24.66M39.97M52.51M68.59M108.97M
Cost of Revenue5.24M7.03M9.7M13.1M32.46M
Gross Profit19.43M32.94M42.81M55.49M76.51M
Gross Margin78.8%82.4%81.5%80.9%70.2%
Research & Development6.05M10.43M12.17M15.23M28.95M
Selling, General & Admin10.41M13.97M18.8M24.56M35.39M
Operating Expenses19.13M28.28M42.81M45.75M64.34M
Depreciation & Amortization2.68M3.87M4.98M5.96M11.08M
EBITDA1.12M5.25M10.38M11.9M23.25M
EBITDA Margin4.5%13.1%19.8%17.4%21.3%
Operating Income324.33K4.66M6.86M9.74M12.17M
Operating Margin1.3%11.7%13.1%14.2%11.2%
Interest Income29.55K0489.57K1.95M2.42M
Interest Expense82.43K70.35K71.98K43.01K70.35K
Other Income / Expenses(1.94M)(6.28M)(1.53M)(3.85M)(6.27M)
Income Before Tax(1.61M)1.31M5.33M5.9M5.9M
Pre-Tax Margin-6.5%3.3%10.1%8.6%5.4%
Income Tax Expense333.08K92.08K778.25K2.9M(209.56K)
Net Income(1.95M)1.21M4.55M3M6.11M
Net Margin-7.9%3.0%8.7%4.4%5.6%
EPS (Basic)(0.05)0.030.100.060.10
EPS (Diluted)(0.05)0.030.100.060.10
Weighted Avg Shares36.4M41.49M43.65M49.2M58.54M
Weighted Avg Shares (Diluted)36.4M42.56M46.6M50.93M60.29M

Vitalhub Corp.

TSX:VHI.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.